From: Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features
AUROC | 95% CI | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |
---|---|---|---|---|---|---|
Pretreatment PLT count | 0.606 | 0.501–0.711 | 50.0 | 70.9 | 63.6 | 58.2 |
Number of nodules | 0.613 | 0.508–0.718 | 58.9 | 63.6 | 62.3 | 60.3 |
Irregular margin | 0.640 | 0.537–0.744 | 57.1 | 70.9 | 66.7 | 61.9 |
Clinical combined model | 0.755 | 0.663–0.846 | 78.6 | 69.1 | 72.1 | 76.0 |